Infliximab for Steroid-Refractory Immune Checkpoint Inhibitor-Induced Acute Pancreatitis

por Townsend, Matthew J., Hodi, F. Stephen, Grover, Shilpa
Publicado 2023

Activity of the Heat Shock Protein 90 Inhibitor Ganetespib in Melanoma

por Wu, Xinqi, Marmarelis, Melina E., Hodi, F. Stephen
Publicado 2013

Corticosteroids and immune checkpoint blockade

por Min, Le, Hodi, F. Stephen, Kaiser, Ursula B.
Publicado 2015

Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial...

por Ott, Patrick A., Hodi, F. Stephen, Buchbinder, Elizabeth I.
Publicado 2015

Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome

por Nishino, Mizuki, Giobbie-Hurder, Anita, Ramaiya, Nikhil H, Hodi, F Stephen
Publicado 2014

Unique cytologic features of thyroiditis caused by immune checkpoint inhibitor therapy for malignant melanoma

por Angell, Trevor E., Min, Le, Wieczorek, Tad J., Hodi, F. Stephen
Publicado 2017

Standardized 11-color flow cytometry panel for the functional phenotyping of human T regulatory cells

por Manuszak, Claire, Brainard, Martha, Thrash, Emily, Hodi, F. Stephen, Severgnini, Mariano
Publicado 2020

Optimizing immune-related tumor response assessment: does reducing the number of lesions impact response assessment in melanoma patients treated with ipilimumab?

por Nishino, Mizuki, Gargano, Maria, Suda, Margaret, Ramaiya, Nikhil H, Hodi, F Stephen
Publicado 2014

The Protein Kinase C Inhibitor Enzastaurin Exhibits Antitumor Activity against Uveal Melanoma

por Wu, Xinqi, Zhu, Meijun, Fletcher, Jonathan A., Giobbie-Hurder, Anita, Hodi, F. Stephen
Publicado 2012

Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI)

por Bartell, Heddy, Wolchok, Jedd, Hodi, F Stephen, Liu, Helen, Wojtaszek, Cynthia, Weber, Jeffrey
Publicado 2015

Cancer immunotherapy trials: leading a paradigm shift in drug development

por Emens, Leisha A., Butterfield, Lisa H., Hodi, F. Stephen, Marincola, Francesco M., Kaufman, Howard L.
Publicado 2016

Combination immunotherapy: a road map

por Ott, Patrick A., Hodi, F. Stephen, Kaufman, Howard L., Wigginton, Jon M., Wolchok, Jedd D.
Publicado 2017

Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features

por Schoenfeld, Jonathan D., Nishino, Mizuki, Severgnini, Mariano, Manos, Michael, Mak, Raymond H., Hodi, F. Stephen
Publicado 2019

Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis

por Elias, Rawad, Giobbie-Hurder, Anita, McCleary, Nadine Jackson, Ott, Patrick, Hodi, F. Stephen, Rahma, Osama
Publicado 2018

High-Throughput Mass Cytometry Staining for Immunophenotyping Clinical Samples

por Thrash, Emily M., Kleinsteuber, Katja, Hathaway, Emma S., Nazzaro, Matthew, Haas, Eric, Hodi, F. Stephen, Severgnini, Mariano
Publicado 2020

OR19-5 The Impact Of High Dose Glucocorticoids On The Outcome Of Immune Checkpoint Inhibitor-related Thyroid Disorders And The Baseline TSH As A Predictive Biomarker

por Min, Le, Ma, Chanjuan, Hodi, F. Stephen, Giobbie-Hurder, Anita, Barroso-Sousa, Romualdo, Tolaney, Sara, Kaiser, Ursula
Publicado 2019

Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma

por Zhou, Jun, Yuen, Noah K., Zhan, Qian, Velazquez, Elsa F., Murphy, George F., Giobbie-Hurder, Anita, Hodi, F. Stephen
Publicado 2011

Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab

por Yuan, Jianda, Zhou, Jun, Dong, Zhiwan, Tandon, Sapna, Kuk, Deborah, Panageas, Katherine S, Wong, Philip, Wolchok, Jedd D, Hodi, F Stephen
Publicado 2013

Immunoprofiling of T cell responses in melanoma patients undergoing CPI therapy

por Talarico, Lee Ann, Grubaugh, Daniel, Yan, Zheng, Alami, Aula, Bodmer, Jean-Luc, Higgins, Darren E, Hodi, F Stephen, Flechtner, Jessica
Publicado 2015

Immune-related response assessment during PD-1 inhibitor therapy in advanced non-small-cell lung cancer patients

por Nishino, Mizuki, Ramaiya, Nikhil H., Chambers, Emily S., Adeni, Anika E., Hatabu, Hiroto, Jänne, Pasi A., Hodi, F. Stephen, Awad, Mark M.
Publicado 2016